January 05, 2023 Flotations fail to bounce back 2022 saw just 19 initial public offerings of drug developers, the lowest total since 2012.
October 04, 2022 The biopharma flotation remains a rare beast Few developers are feeling bold enough to brave the markets, though the bigger deals are finding some support.
